Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers Publication Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers See how enteric‑coated tablet shows higher bioavailability and delayed peak vs capsule, analysed using Phoenix…Certara2023 年 6 月 16 日
Liquid Chromatography-Tandem Mass Spectrometry Method for Detection and Quantification of Meloxicam and 5′-Carboxymeloxicam in Oral Fluid Samples Publication Liquid Chromatography-Tandem Mass Spectrometry Method for Detection and Quantification of Meloxicam and 5′-Carboxymeloxicam in Oral Fluid Samples Learn how oral‑fluid LC‑MS/MS enables minimally invasive meloxicam PK/PD assessment, analysed using Phoenix WinNonlin.Certara2023 年 6 月 15 日
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program Case Study 利用药代动力学建模和科学传播专长推进肉样瘤病药物项目 Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…Certara2023 年 6 月 1 日
Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis Publication Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis Find out how sex affects ivermectin peripheral distribution; infection status does not, modelled using Phoenix…Certara2023 年 6 月 1 日
American College of Toxicology 2026 Annual Meeting Conference American College of Toxicology 2026 Annual Meeting – – BoothKevin Snyder, PhD2023 年 5 月 24 日
Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes Publication Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes Explore how high‑altitude hypoxia increases metformin AUC and half‑life; PK‑PD modelling supports extended dosing intervals.Certara2023 年 4 月 28 日
Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study Publication Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study Discover how AUC/MIC ≥ 66.9 predicts efficacy; modelling supports 75–100 mg q12h dosing for CRO…Certara2023 年 4 月 28 日
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans Publication Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans See how tablet and capsule are bioequivalent; food delays Tmax without affecting exposure, analysed using…Certara2023 年 3 月 17 日
Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients Publication Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients Learn how PopPK modelling supports limited sampling strategies and individualized polymyxin B dosing using Phoenix…Certara2023 年 3 月 2 日
Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC-MS/MS in Sprague-Dawley rats Publication Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC-MS/MS in Sprague-Dawley rats Simultaneous PK profiling of four fenugreek phytochemicals in rats, supporting development of fenugreek‑based formulations by…Certara2023 年 2 月 27 日